**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 71098-88-9 |N-(Phenylseleno)phthalimide | 100 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T N
Risk Phrases: 23/25 33 50/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Toxic by inhalation and if swallowed. Danger of cumulative effects.
Very toxic to aquatic organisms, may cause long-term adverse effects
in the aquatic environment.Moisture sensitive.The toxicological
properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May be harmful if absorbed through the
skin.
Ingestion:
May cause irritation of the digestive tract. Poison by ingestion.
May cause liver damage. The toxicological properties of this
substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated. Toxic if inhaled.
Chronic:
Chronic exposure to selenium may cause pallor, garlic breath,
metallic taste, anemia, liver and spleen damage. Chronic selenium
poisoning is characterized by loss of hair and nails, skin lesions,
and abnormalities of the nervous system.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes.
Ingestion:
Get medical aid immediately. Wash mouth out with water. If
swallowed, do not induce vomiting unless directed to do so by medical
personnel. Never give anything by mouth to an unconscious person. Get
medical aid.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If breathing is difficult, give oxygen. Do NOT use
mouth-to-mouth resuscitation. If breathing has ceased apply
artificial respiration using oxygen and a suitable mechanical device
such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Minimize dust generation and
accumulation. Do not breathe dust, vapor, mist, or gas. Do not get in
eyes, on skin, or on clothing. Keep container tightly closed. Use
only in a chemical fume hood.
Storage:
Store in a tightly closed container. Keep under a nitrogen blanket.
Deep freeze (below -20C). Store protected from moisture.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 71098-88-9:
United Kingdom, WEL - TWA: (listed as selenium compounds): 0.1 mg
TWA (except hydrogen selenide, as Se)
United Kingdom, WEL - STEL: (listed as selenium compounds): 0.3 m
STEL (except hydrogen selenide, as Se)
United States OSHA: 0.2 mg/m3 TWA (as Se) (listed under Selenium
compounds).
Belgium - TWA: (listed as selenium compounds): 0.2 mg/m3 VLE (as
Japan: (listed as selenium compounds): 0.1 mg/m3 OEL (except SeH2
SeF6, as Se)
Malaysia: (listed as selenium compounds): 0.2 mg/m3 TWA (as Se)
Netherlands: (listed as selenium compounds): 0.1 mg/m3 MAC (as Se
Spain: (listed as selenium compounds): 0.1 mg/m3 VLA-ED (except
hydrogen selenide, as Se)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystalline powder
Color: white to light yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 181 - 184 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C14H9NO2Se
Molecular Weight: 302.0285
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Moisture accelerates decomposition. Moisture sensitive.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, exposure to
moist air or water.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, selenium/selenium
oxides.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 71098-88-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
N-(Phenylseleno)phthalimide -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: SELENIUM COMPOUND, N.O.S.
Hazard Class: 6.1
UN Number: 3283
Packing Group: II
IMO
Shipping Name: SELENIUM COMPOUND, N.O.S.
Hazard Class: 6.1
UN Number: 3283
Packing Group: II
RID/ADR
Shipping Name: SELENIUM COMPOUND, N.O.S.
Hazard Class: 6.1
UN Number: 3283
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T N
Risk Phrases:
R 23/25 Toxic by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
Safety Phrases:
S 20/21 When using do not eat, drink or smoke.
S 28A After contact with skin, wash immediately with
plenty of water.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 60 This material and its container must be
disposed of as hazardous waste.
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 71098-88-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 71098-88-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 71098-88-9 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 7/19/2000 Revision #3 Date: 3/16/2005
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Methyl 4-amino-3-bromobenzoate
| 106896-49-5 |
|
2,4-Dichloro-5-hydroxyaniline
| 39489-79-7 |
|
6-Chloro-4-trifluoromethoxyaniline
| 0-01-1 |
|
2,4-Dibromo-6-methylaniline
| 30273-41-7 |
|
1,4-Bis(trichloromethyl)benzene, 99%
| 68-36-0 |
|
Nicotinamide, p.a.
| 98-92-0 |
|
6-Chloro-9-(3-N-(2-chloroethyl-amino)-propylamino-2-methoxyacridine
| 17064-47-0 |
|
2-Amino-5-bromobenzotrifluoride
| 445-02-3 |
|
N,N'-p-Phenylenedimaleimide
| 3278-31-7 |
|
N,N'-m-Phenylenedimaleimide
| 3006-93-7 |
|
Allyltrimethylsilane, 97%
| 762-72-1 |
|
Celite 545
| 68855-54-9 |
|
3-Bromo-1-propanol, 97%
| 627-18-9 |
|
1,2-Epoxy-2-methylbutane
| 30095-63-7 |
|
2,3-Epoxy-2-methylbutane
| 5076-19-7 |
|
Dicyclopentadiene diepoxide
| 81-21-0 |
|
1-(3-Methylphenyl)-piperazine, 99%
| 41186-03-2 |
|
Lithium bis(trimethylsilyl)amide, 23% in methyl tert-butyl ether
| 100-41-4 |
|
Lithium bis(trimethylsilyl)amide, 20% in THF
| 100-41-4 |
|
2(2-Bromoethyl)-1,3-dioxolane, 96%
| 18742-02-4 |
|
N-(Phenylseleno)phthalimide, tech.
| 71098-88-9 |
|
Brij?? 98
| 9004-98-2 |
|
4-Fluoro-N-methylaniline
| 459-59-6 |
|
3,4,5-Trimethoxyacetophenone, 99+%
| 1136-86-3 |
|
Potassium tetracyanonickelate(II) hydrate
| 14220-17-8 |
|
Zinc peroxide, 55%
| 1314-22-3 |
|
3,4-Dimethyl-3,4-diphenylhexane
| 10192-93-5 |
|
1,4-Naphthalenediol (pract), 95% (uv-vis)
| 571-60-8 |
|
2,3-Dimethyl-2,3-diphenylbutane
| 1889-67-4 |
|
Dicumyl peroxide
| 80-43-3 |
|
Cumyl hydroperoxide
| 80-15-9 |
|
tert-Butyl cumyl peroxide
| 98-82-8 |
|
3,6,9-Triethyl-3,6,9-trimethyl-1,4,7-triperoxynonane, 41% solution in
| 24748-23-0 |
|
Di(tert-butylperoxyisopropyl)benzene
| 2212-81-9 |
|
tert-Butyl peroxy-3,5,5-trimethylhexanoate
| 13122-18-4 |
|
tert-Butylperoxy 2-ethylhexyl carbonate
| 34443-12-4 |
|
Di-tert-butyl peroxide
| 110-05-4 |
|
1,1-Di(tert-butylperoxy)cyclohexane, 50% solution in aromatic free
| 3006-86-8 |
|
Lauroyl peroxide
| 105-74-8 |
|
tert-Butyl peroxyacetate, 50% solution in aromatic free mineral
| 107-71-1 |
|
2,5-Dimethyl-2,5-di(tert-butylperoxy)hexane
| 78-63-7 |
|
2,2-Di(tert-butylperoxy)butane, 50% solution in aromatic free mineral
| 78-93-3 |
|
Benzoylformic acid, 97%
| 611-73-4 |
|
Ethyl 7-bromoheptanoate
| 29823-18-5 |
|
16-Hydroxyhexadecanoic Acid, 98%
| 506-13-8 |
|
4-(4,6-Dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride
| 0-00-0 |
|
3-Methoxysalicylic acid, 97%
| 877-22-5 |
|
d-alpha-Tocopherylquinone, 90-95%
| 7559-04-8 |
|
Dibutyl Maleate
| 105-76-0 |
|
Glutathione-Agarose, 4% cross-linked
| 0-01-1 |
|
|